A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease that lack of effective therapeutic drugs. K-001 is an oral antitumor drug made from active ingredients of marine microorganisms. The current study aimed to evaluate safety and antitumor activity of K-001 in patients with advance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Cui, Jiujie, Yang, Haiyan, Liu, Jue, Chen, Donghui, Hu, Jiong, Zhang, Haiyan, Wang, Yu, Han, Ting, Mao, Tiebo, Jiao, Feng, Biskup, Ewelina, Pan, Yaotian, Liu, Min, Wang, Liwei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183060/
https://ncbi.nlm.nih.gov/pubmed/34098895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08375-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados